Clinically Relevant Drug Transporters: Understanding DDI with a View to Better Prediction and Control
Hosted By : Andrea CharlesDecember 15, 2011
About this Podcast...
How is the industry seeking to understanding DDI with a view to better prediction and control? How has the current technology landscape changed following the publication of the ITC white paper? What progress do you expect we will see in clinically relevant drug transporters in 2012? Drug transporters exert a vital influence on drug absorption, disposition, metabolism and elimination and are seen as an essential part of predicting drug disposition. However, identifying and employing the right membrane transporters remains a challenge as does the interpretation and translation of transport data. In this interview Dr. James Clarke, Senior Scientist, GlaxoSmithKline, speaks to Andrea Charles from Pharma IQ, about the biggest challengs for clinically revelant drug transporters.
|
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
-
3rd Annual Clinically Relevant Drug Transporters
Venue to be confirmed, London, UK
October 30- 31, 2012 -
Global Formulation and Drug Delivery Summit 2012
Park Hotel Amsterdam, Netherlands
April 16- 18, 2012 -
4th Clinical Trials Supply & Logistics Summit
San Francisco, CA
June 25- 27, 2012 -
Predictive Toxicology Summit
Boston, MA
May 21- 23, 2012






Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!